Tilray Brands Reports Q1 2025 Financial Results
Tilray Brands reported strong Q1 2025 financial results, with net revenue increasing 13% year-over-year to $200 million. The company saw significant growth across various segments:
- Beverage alcohol net revenue surged 132% to $56.0 million
- Cannabis net revenue reached $61.2 million with a 40% gross margin
- Distribution net revenue was $68.1 million
- Wellness net revenue grew 11% to $14.8 million
Gross profit increased by 35% to $59.7 million, with gross margin improving to 30%. The company's net loss improved by 38% to $(34.7) million. Tilray's CEO, Irwin D. Simon, expressed optimism about potential regulatory changes in the U.S. cannabis industry following the upcoming presidential elections.
Tilray Brands ha riportato risultati finanziari solidi per il primo trimestre del 2025, con un aumento del fatturato netto del 13% rispetto all'anno precedente, arrivando a $200 milioni. L'azienda ha registrato una crescita significativa in vari settori:
- Il fatturato netto delle bevande alcoliche è aumentato del 132% fino a raggiungere i $56,0 milioni
- Il fatturato netto della cannabis ha raggiunto i $61,2 milioni con un margine lordo del 40%
- Il fatturato netto della distribuzione è stato di $68,1 milioni
- Il fatturato netto del benessere è cresciuto dell'11% fino a $14,8 milioni
Il profitto lordo è aumentato del 35% arrivando a $59,7 milioni, con un margine lordo in miglioramento al 30%. La perdita netta dell'azienda è stata ridotta del 38%, arrivando a $(34,7) milioni. Il CEO di Tilray, Irwin D. Simon, ha espresso ottimismo riguardo ai potenziali cambiamenti normativi nell'industria della cannabis negli Stati Uniti dopo le imminenti elezioni presidenziali.
Tilray Brands reportó resultados financieros sólidos para el primer trimestre de 2025, con un aumento del ingreso neto del 13% en comparación con el año anterior, alcanzando los $200 millones. La empresa vio un crecimiento significativo en varios segmentos:
- Los ingresos netos por bebidas alcohólicas aumentaron un 132% hasta $56,0 millones
- Los ingresos netos por cannabis alcanzaron $61,2 millones con un margen bruto del 40%
- Los ingresos netos por distribución fueron de $68,1 millones
- Los ingresos netos por bienestar crecieron un 11% hasta $14,8 millones
El beneficio bruto aumentó un 35% hasta $59,7 millones, con un margen bruto mejorando al 30%. La pérdida neta de la compañía mejoró en un 38% hasta $(34,7) millones. El CEO de Tilray, Irwin D. Simon, expresó optimismo sobre los posibles cambios regulatorios en la industria del cannabis en EE. UU. tras las próximas elecciones presidenciales.
틸레이 브랜드는 2025년 1분기 강력한 재무 결과를 보고했으며, 순 매출이 전년 대비 13% 증가하여 2억 달러에 달했습니다. 회사는 여러 분야에서 상당한 성장을 경험했습니다:
- 알콜 음료의 순 매출은 132% 증가하여 5,600만 달러에 이르렀습니다
- 대마초의 순 매출은 6,120만 달러에 도달했으며, 총 이익률은 40%입니다
- 유통의 순 매출은 6,810만 달러였습니다
- 웰니스의 순 매출은 11% 증가하여 1,480만 달러에 이르렀습니다
총 이익은 35% 증가하여 5,970만 달러에 달하며, 총 이익률은 30%로 개선되었습니다. 회사의 순손실은 38% 개선되어 $(3,470만) 달러가 되었습니다. 틸레이의 CEO인 어윈 D. 사이먼은 다가오는 대통령 선거 후 미국 대마초 산업의 규제 변화에 대한 낙관적인 견해를 표현했습니다.
Tilray Brands a annoncé de solides résultats financiers pour le premier trimestre 2025, avec une augmentation du chiffre d'affaires net de 13% par rapport à l'année dernière, atteignant 200 millions de dollars. L'entreprise a connu une croissance significative dans divers segments :
- Le chiffre d'affaires net des boissons alcoolisées a bondi de 132% pour atteindre 56,0 millions de dollars
- Le chiffre d'affaires net du cannabis a atteint 61,2 millions de dollars avec une marge brute de 40%
- Le chiffre d'affaires net de la distribution s'est élevé à 68,1 millions de dollars
- Le chiffre d'affaires net du bien-être a augmenté de 11% pour atteindre 14,8 millions de dollars
Le bénéfice brut a augmenté de 35% pour atteindre 59,7 millions de dollars, avec une marge brute améliorée à 30%. La perte nette de l'entreprise s'est améliorée de 38% pour s'établir à (34,7 millions) de dollars. Le PDG de Tilray, Irwin D. Simon, a exprimé son optimisme quant aux changements réglementaires potentiels dans l'industrie du cannabis aux États-Unis après les prochaines élections présidentielles.
Tilray Brands hat für das erste Quartal 2025 starke Finanzergebnisse gemeldet, mit einem Anstieg des Nettoumsatzes um 13% im Vergleich zum Vorjahr auf 200 Millionen USD. Das Unternehmen verzeichnete ein signifikantes Wachstum in verschiedenen Bereichen:
- Nettoumsatz aus alkoholischen Getränken stieg um 132% auf 56,0 Millionen USD
- Nettoumsatz aus Cannabis erreichte 61,2 Millionen USD mit einer Bruttomarge von 40%
- Nettoumsatz aus Distribution betrug 68,1 Millionen USD
- Nettoumsatz aus Wellness wuchs um 11% auf 14,8 Millionen USD
Der Bruttogewinn stieg um 35% auf 59,7 Millionen USD, wobei die Bruttomarge auf 30% verbessert wurde. Der Nettoverlust des Unternehmens verbesserte sich um 38% auf (34,7 Millionen) USD. Der CEO von Tilray, Irwin D. Simon, äußerte sich optimistisch über mögliche regulatorische Änderungen in der Cannabisbranche der USA nach den bevorstehenden Präsidentschaftswahlen.
- Net revenue increased 13% year-over-year to $200 million
- Gross profit increased by 35% to $59.7 million
- Gross margin improved from 25% to 30% year-over-year
- Beverage alcohol net revenue surged 132% to $56.0 million
- Wellness net revenue grew 11% to $14.8 million
- Net loss improved by 38% to $(34.7) million
- Net loss per share improved from $(0.10) to $(0.04)
- German medical cannabis flower revenue increased by 50%
- Company still reported a net loss of $(34.7) million
- Adjusted EBITDA decreased from $10.7 million to $9.3 million year-over-year
Insights
Tilray Brands' Q1 2025 results show significant progress, with 13% year-over-year revenue growth to
Key positives include the
Overall, Tilray's strategic focus on diversification and operational efficiency is showing results, but profitability remains a challenge. The stock may be volatile as the market digests these mixed signals.
Tilray's Q1 results reflect a company successfully navigating a complex and evolving market landscape. The
The company's expansion in Germany with a
However, investors should be cautious about over-reliance on potential U.S. regulatory changes. While both presidential candidates have expressed support for further legalization, the timeline and extent of such changes remain uncertain. Tilray's current focus on hemp-derived products in the U.S. is a prudent strategy to establish a foothold without running afoul of federal regulations.
Tilray Achieves
Q1 Gross Margin Increases Over 500 Basis Points, Representing
Tilray Beverages Achieves
German Medical Cannabis Flower Revenue Increases by
Conference Call to be Held at 8:30 a.m. ET Today
NEW YORK and LEAMINGTON, Ontario, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today reported financial results for its first quarter ended August 31, 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
Irwin D. Simon, Tilray Brands’ Chairman and Chief Executive Officer, stated, “As the Chairman and CEO of Tilray Brands, I am excited to lead a company that is disrupting the CPG industry through innovative products that are transforming the way consumers eat, drink, and unwind with cannabis, hemp and beverage products. Our investments in the cannabis, wellness, beverage, and distribution industries are focused on shaping the future and staying ahead of the curve. We are dedicated to executing our strategic plan to increase revenue, drive operational efficiencies, and improve margins and profitability while investing in our continued growth. Our commitment to innovation and growth is unwavering.”
Mr. Simon, continued, “We believe that there is a greater likelihood that the upcoming U.S. Presidential elections will result in improved regulatory changes in the cannabis industry, as both candidates have publicly confirmed their support for further legalization. We are optimistic about the future of the cannabis industry and look forward to the potential opportunities that lie ahead.”
Financial Highlights – First Quarter Fiscal Year 2025
- Net revenue increased
13% to$200 million in the first quarter compared to$177 million in the prior year quarter. - Gross profit increased by
35% to$59.7 million in the first quarter compared to$44.2 million in the prior year quarter. Gross margin increased to30% in the first quarter compared to25% in the prior year quarter. - Net loss improved by
38% to$(34.7) million in the first quarter compared to$(55.9) million in the prior year quarter. - Net loss per share improved to
$(0.04) in the first quarter compared to$(0.10) in the prior year quarter. - Adjusted net loss per share improved to
$(0.01) in the first quarter compared to$(0.04) in the prior year quarter. - Adjusted EBITDA in the first quarter was
$9.3 million compared to$10.7 million in the prior year quarter. - Beverage alcohol net revenue including acquisitions increased
132% to$56.0 million in the first quarter.- Beverage alcohol gross margin was
41% in the first quarter.
- Beverage alcohol gross margin was
- Cannabis net revenue was
$61.2 million in the first quarter.- Cannabis gross margin was
40% in the first quarter.
- Cannabis gross margin was
- Distribution net revenue was
$68.1 million in the first quarter.- Distribution gross margin was
12% in the first quarter.
- Distribution gross margin was
- Wellness net revenue increased
11% to$14.8 million in first the quarter.- Wellness gross margin was
32% in the first quarter.
- Wellness gross margin was
Live Conference Call and Audio Webcast
Tilray Brands will host a webcast to discuss these results today at 8:30 a.m. ET. Investors may join the live webcast available on the Investors section of the Company’s website at www.tilray.com. A replay will be available and archived on the Company’s website.
About Tilray Brands
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.
For more information on Tilray Brands, visit www.Tilray.com and follow @Tilray
Cautionary Statement Concerning Forward-Looking Statements
Certain statements in this press release constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication.
Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the Company’s ability to disrupt the CPG industry for cannabis, hemp, and beverage consumption; the Company’s ability to become a leading beverage alcohol Company; the Company’s ability to achieve long term profitability; the Company’s ability to achieve operational scale, market share, distribution, profitability and revenue growth in particular business lines and markets; the Company’s ability to successfully achieve revenue growth, margin and profitability improvements, production and supply chain efficiencies, synergies and cost savings; the Company’s expected revenue growth, sales volume, profitability, synergies and accretion related to any of its acquisitions; expected commercial opportunities and regulatory developments in the U.S., including upon U.S. federal cannabis legalization or rescheduling; the Company’s anticipated investments and acquisitions, including in organic and strategic growth, partnership efforts, product offerings and other initiatives; the Company’s ability to commercialize new and innovative products; market opportunities and regulatory risks for Hemp-Derived Delta-9 (HDD9) beverage products, and expected sales, distribution, margin, price and revenue generation projections; consumer sentiment regarding HDD9 beverage products; and Tilray’s strategy and anticipated offerings within the HDD9 beverage product segment.
Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of the Company and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of the Company made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
Use of Non-U.S. GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including Adjusted gross margin (consolidated and for each of our reporting segments), Adjusted gross profit (consolidated and for each of our reporting segments), Adjusted EBITDA, Adjusted net income (loss), Adjusted net income (loss) per share, free cash flow, adjusted free cash flow, constant currency presentations of revenue and cash and marketable securities. Management believes that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the Company's operations and are useful for period-over-period comparisons of operations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the Company's Consolidated Statements of Operations and Cash Flows presented in accordance with GAAP.
Certain forward-looking non-GAAP financial measures included in this press release are not reconciled to the comparable forward-looking GAAP financial measures. The Company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the Company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Such items may include litigation and related expenses, transaction costs, impairments, foreign exchange movements and other items. The unavailable information could have a significant impact on the Company's GAAP financial results.
The Company believes presenting net sales at constant currency provides useful information to investors because it provides transparency to underlying performance in the Company's consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year. A reconciliation of prior year revenue to constant currency revenue the most directly comparable GAAP measure, has been provided in the financial statement tables included above in this press release.
Adjusted EBITDA is calculated as net income (loss) before income tax benefits, net; interest expense, net; non-operating income (expense), net; amortization; stock-based compensation; change in fair value of contingent consideration; purchase price accounting step-up; facility start-up and closure costs; litigation costs; restructuring costs, and transaction (income) costs, net. A reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Historically, we have included lease expenses for leases that were treated differently under IFRS 16 and ASC 842 in the calculation of adjusted EBITDA, aiming to align our definition with industry peers reporting under IFRS. The decision to include these lease expenses in the Company's definition of adjusted EBITDA was based on our efforts to maintain comparability with peers. However, as the Company has continued to diversify, particularly with strategic acquisitions such as the newly acquired beverage alcohol business portfolio, this comparison is no longer relevant, accordingly, we are no longer including this adjustment. Had the Company continued to include lease expenses that were treated differently under IFRS 16 and ASC 842, the impact to adjusted EBITDA would have been
Adjusted net income (loss) is calculated as net loss attributable to stockholders of Tilray Brands, Inc., less; non-operating income (expense), net; amortization; stock-based compensation; change in fair value of contingent consideration; facility start-up and closure costs; litigation costs; restructuring costs and transaction (income) costs, net. A reconciliation of Adjusted net income (loss) to net loss attributable to stockholders of Tilray Brands, Inc., the most directly comparable GAAP measure, has been included below in this press release.
Adjusted net income (loss) per share is calculated as net loss attributable to stockholders of Tilray Brands, Inc., net; non-operating income (expense), net; amortization; stock-based compensation; change in fair value of contingent consideration; facility start-up and closure costs; litigation costs; restructuring costs and transaction (income) costs, divided by weighted average number of common shares outstanding. A reconciliation of Adjusted net income (loss) per share to net loss attributable to stockholders of Tilray Brands, Inc., the most directly comparable GAAP measure, has been included below in this press release. Adjusted net income (loss) per share is not calculated in accordance with GAAP and should not be considered an alternative for GAAP net income (loss) per share or as a measure of liquidity.
Adjusted gross profit (consolidated and for each of our reporting segments), is calculated as gross profit adjusted to exclude the impact of purchase price accounting valuation step-up. A reconciliation of Adjusted gross profit, excluding purchase price accounting valuation step-up, to gross profit, the most directly comparable GAAP measure, has been provided in the financial statement tables included above in this press release. Adjusted gross margin (consolidated and for each of our reporting segments), excluding purchase price accounting valuation step-up, is calculated as revenue less cost of sales adjusted to add back amortization of inventory step-up, divided by revenue. A reconciliation of Adjusted gross margin, excluding purchase price accounting valuation step-up, to gross margin, the most directly comparable GAAP measure, has been provided in the financial statement tables included above in this press release.
Free cash flow is comprised of two GAAP measures which are net cash flow provided by (used in) operating activities less investments in capital and intangible assets, net. A reconciliation of net cash flow provided by (used in) operating activities to free cash flow, the most directly comparable GAAP measure, has been provided in the financial statement tables included above in this press release. Adjusted free cash flow is comprised of two GAAP measures which are net cash flow provided by (used in) operating activities less investments in capital and intangible assets, net, and the exclusion of growth CAPEX from investments in capital and intangible assets, net, which excludes the amount of capital expenditures that are considered to be associated with growth of future operations rather than to maintain the existing operations of the Company, and excludes our integration costs related to HEXO and the cash income taxes related to Aphria Diamond to align with management’s prescribed guidance. A reconciliation of net cash flow provided by (used in) operating activities to adjusted free cash flow, the most directly comparable GAAP measure, has been provided in the financial statement tables included above in this press release.
Cash and marketable securities are comprised of two GAAP measures, cash and cash equivalents added to marketable securities. The Company’s management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its short-term liquidity position by combing these two GAAP metrics.
For further information:
Media Contact: news@tilray.com
Investor Contact: investors@tilray.com
| Consolidated Statements of Financial Position | |||||||
| August 31, | May 31, | ||||||
| (in thousands of US dollars) | 2024 | 2024 | |||||
| Assets | |||||||
| Current assets | |||||||
| Cash and cash equivalents | $ | 205,186 | $ | 228,340 | |||
| Marketable securities | 74,869 | 32,182 | |||||
| Accounts receivable, net | 104,037 | 101,695 | |||||
| Inventory | 264,295 | 252,087 | |||||
| Prepaids and other current assets | 44,960 | 31,332 | |||||
| Assets held for sale | 32,536 | 32,074 | |||||
| Total current assets | 725,883 | 677,710 | |||||
| Capital assets | 555,136 | 558,247 | |||||
| Operating lease, right-of-use assets | 17,176 | 16,101 | |||||
| Intangible assets | 908,768 | 915,469 | |||||
| Goodwill | 2,009,714 | 2,008,884 | |||||
| Long-term investments | 7,853 | 7,859 | |||||
| Convertible notes receivable | 32,000 | 32,000 | |||||
| Other assets | 5,337 | 5,395 | |||||
| Total assets | $ | 4,261,867 | $ | 4,221,665 | |||
| Liabilities | |||||||
| Current liabilities | |||||||
| Bank indebtedness | $ | 18,134 | $ | 18,033 | |||
| Accounts payable and accrued liabilities | 236,146 | 241,957 | |||||
| Contingent consideration | 15,000 | 15,000 | |||||
| Warrant liability | 2,557 | 3,253 | |||||
| Current portion of lease liabilities | 5,640 | 5,091 | |||||
| Current portion of long-term debt | 16,072 | 15,506 | |||||
| Current portion of convertible debentures payable | — | 330 | |||||
| Total current liabilities | 293,549 | 299,170 | |||||
| Long - term liabilities | |||||||
| Lease liabilities | 60,657 | 60,422 | |||||
| Long-term debt | 155,268 | 158,352 | |||||
| Convertible debentures payable | 132,650 | 129,583 | |||||
| Deferred tax liabilities, net | 136,230 | 130,870 | |||||
| Other liabilities | 99 | 90 | |||||
| Total liabilities | 778,453 | 778,487 | |||||
| Stockholders' equity | |||||||
| Common stock ( | 88 | 83 | |||||
| Preferred shares ( | — | — | |||||
| Additional paid-in capital | 6,217,533 | 6,146,810 | |||||
| Accumulated other comprehensive loss | (39,877 | ) | (43,499 | ) | |||
| Accumulated deficit | (2,699,653 | ) | (2,660,488 | ) | |||
| Total Tilray Brands, Inc. stockholders' equity | 3,478,091 | 3,442,906 | |||||
| Non-controlling interests | 5,323 | 272 | |||||
| Total stockholders' equity | 3,483,414 | 3,443,178 | |||||
| Total liabilities and stockholders' equity | $ | 4,261,867 | $ | 4,221,665 | |||
| Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) | ||||||||||||||
| For the three months ended | ||||||||||||||
| August 31, | August 31, | Change | % Change | |||||||||||
| (in thousands of U.S. dollars, except for per share data) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||
| Net revenue | $ | 200,044 | $ | 176,949 | $ | 23,095 | 13 | % | ||||||
| Cost of goods sold | 140,338 | 132,753 | 7,585 | 6 | % | |||||||||
| Gross profit | 59,706 | 44,196 | 15,510 | 35 | % | |||||||||
| Operating expenses: | ||||||||||||||
| General and administrative | 44,113 | 40,516 | 3,597 | 9 | % | |||||||||
| Selling | 11,690 | 6,859 | 4,831 | 70 | % | |||||||||
| Amortization | 21,804 | 22,225 | (421 | ) | (2 | )% | ||||||||
| Marketing and promotion | 11,566 | 8,535 | 3,031 | 36 | % | |||||||||
| Research and development | 105 | 79 | 26 | 33 | % | |||||||||
| Change in fair value of contingent consideration | — | (11,107 | ) | 11,107 | (100 | )% | ||||||||
| Litigation costs, net of recoveries | 1,595 | 2,034 | (439 | ) | (22 | )% | ||||||||
| Restructuring costs | 4,247 | 915 | 3,332 | 364 | % | |||||||||
| Transaction costs (income), net | 1,156 | 8,502 | (7,346 | ) | (86 | )% | ||||||||
| Total operating expenses | 96,276 | 78,558 | 17,718 | 23 | % | |||||||||
| Operating loss | (36,570 | ) | (34,362 | ) | (2,208 | ) | 6 | % | ||||||
| Interest expense, net | (9,842 | ) | (9,835 | ) | (7 | ) | 0 | % | ||||||
| Non-operating income (expense), net | 12,646 | (4,402 | ) | 17,048 | (387 | )% | ||||||||
| Loss before income taxes | (33,766 | ) | (48,599 | ) | 14,833 | (31 | )% | |||||||
| Income tax expense, net | 886 | 7,264 | (6,378 | ) | (88 | )% | ||||||||
| Net loss | $ | (34,652 | ) | $ | (55,863 | ) | $ | 21,211 | (38 | )% | ||||
| Net loss per share - basic and diluted | (0.04 | ) | (0.10 | ) | 0.06 | (60 | )% | |||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||||||
| For the three months ended | ||||||||||||||
| August 31, | August 31, | Change | % Change | |||||||||||
| (in thousands of US dollars) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||
| Cash provided by (used in) operating activities: | ||||||||||||||
| Net loss | $ | (34,652 | ) | $ | (55,863 | ) | $ | 21,211 | (38 | )% | ||||
| Adjustments for: | ||||||||||||||
| Deferred income tax expense, net | 382 | 59 | 323 | 547 | % | |||||||||
| Unrealized foreign exchange (gain) loss | (5,602 | ) | (3,127 | ) | (2,475 | ) | 79 | % | ||||||
| Amortization | 31,814 | 30,789 | 1,025 | 3 | % | |||||||||
| Accretion of convertible debt discount | 3,067 | 5,544 | (2,477 | ) | (45 | )% | ||||||||
| Other non-cash items | 729 | (6,357 | ) | 7,086 | (111 | )% | ||||||||
| Stock-based compensation | 6,917 | 8,257 | (1,340 | ) | (16 | )% | ||||||||
| (Gain) loss on long-term investments & equity investments | (499 | ) | 47 | (546 | ) | (1162 | )% | |||||||
| Loss on derivative instruments | (696 | ) | 10,345 | (11,041 | ) | (107 | )% | |||||||
| Change in fair value of contingent consideration | — | (11,107 | ) | 11,107 | (100 | )% | ||||||||
| Change in non-cash working capital: | ||||||||||||||
| Accounts receivable | (2,342 | ) | 13,044 | (15,386 | ) | (118 | )% | |||||||
| Prepaids and other current assets | (13,570 | ) | (4,654 | ) | (8,916 | ) | 192 | % | ||||||
| Inventory | (12,383 | ) | 3,650 | (16,033 | ) | (439 | )% | |||||||
| Accounts payable and accrued liabilities | (8,472 | ) | (6,469 | ) | (2,003 | ) | 31 | % | ||||||
| Net cash used in operating activities | (35,307 | ) | (15,842 | ) | (19,465 | ) | 123 | % | ||||||
| Cash provided by (used in) investing activities: | ||||||||||||||
| Investment in capital and intangible assets | (6,736 | ) | (4,152 | ) | (2,584 | ) | 62 | % | ||||||
| Proceeds from disposal of capital and intangible assets | 28 | 342 | (314 | ) | (92 | )% | ||||||||
| Disposal (purchase) of marketable securities, net | (42,687 | ) | (45,436 | ) | 2,749 | (6 | )% | |||||||
| Business acquisitions, net of cash acquired | — | 22,956 | (22,956 | ) | (100 | )% | ||||||||
| Net cash provided by (used in) investing activities | (49,395 | ) | (26,290 | ) | (23,105 | ) | 88 | % | ||||||
| Cash provided by (used in) financing activities: | ||||||||||||||
| Share capital issued, net of cash issuance costs | 66,472 | — | 66,472 | NM | ||||||||||
| Proceeds from long-term debt | — | 7,621 | (7,621 | ) | (100 | )% | ||||||||
| Repayment of long-term debt | (4,791 | ) | (6,369 | ) | 1,578 | (25 | )% | |||||||
| Proceeds from convertible debt | — | 21,553 | (21,553 | ) | (100 | )% | ||||||||
| Repayment of convertible debt | (330 | ) | — | (330 | ) | NM | ||||||||
| Repayment of lease liabilities | (862 | ) | — | (862 | ) | NM | ||||||||
| Net increase (decrease) in bank indebtedness | 101 | (8,787 | ) | 8,888 | (101 | )% | ||||||||
| Net cash provided by (used in) financing activities | 60,590 | 14,018 | 46,572 | 332 | % | |||||||||
| Effect of foreign exchange on cash and cash equivalents | 958 | 614 | 344 | 56 | % | |||||||||
| Net decrease in cash and cash equivalents | (23,154 | ) | (27,500 | ) | 4,346 | (16 | )% | |||||||
| Cash and cash equivalents, beginning of period | 228,340 | 206,632 | 21,708 | 11 | % | |||||||||
| Cash and cash equivalents, end of period | $ | 205,186 | $ | 179,132 | $ | 26,054 | 15 | % | ||||||
| Net Revenue by Operating Segment | |||||||||||||
| For the three months ended | % of Total | For the three months ended | % of Total | ||||||||||
| (In thousands of U.S. dollars) | August 31, 2024 | Revenue | August 31, 2023 | Revenue | |||||||||
| Beverage alcohol business | $ | 55,972 | 28 | % | $ | 24,162 | 13 | % | |||||
| Cannabis business | 61,249 | 31 | % | 70,333 | 40 | % | |||||||
| Distribution business | 68,071 | 34 | % | 69,157 | 39 | % | |||||||
| Wellness business | 14,752 | 7 | % | 13,297 | 8 | % | |||||||
| Total net revenue | $ | 200,044 | 100 | % | $ | 176,949 | 100 | % | |||||
| Net Revenue by Operating Segment in Constant Currency | |||||||||||||
| For the three months ended | For the three months ended | ||||||||||||
| August 31, 2024 | August 31, 2023 | ||||||||||||
| (In thousands of U.S. dollars) | as reported in constant currency | % of Total Revenue | as reported in constant currency | % of Total Revenue | |||||||||
| Beverage alcohol business | $ | 55,972 | 27 | % | $ | 24,162 | 13 | % | |||||
| Cannabis business | 62,792 | 31 | % | 70,333 | 40 | % | |||||||
| Distribution business | 70,396 | 35 | % | 69,157 | 39 | % | |||||||
| Wellness business | 14,940 | 7 | % | 13,297 | 8 | % | |||||||
| Total net revenue | $ | 204,100 | 100 | % | $ | 176,949 | 100 | % | |||||
| Net Cannabis Revenue by Market Channel | |||||||||||||
| For the three months ended | % of Total | For the three months ended | % of Total | ||||||||||
| (In thousands of U.S. dollars) | August 31, 2024 | Revenue | August 31, 2023 | Revenue | |||||||||
| Revenue from Canadian medical cannabis | $ | 6,261 | 10 | % | $ | 6,142 | 9 | % | |||||
| Revenue from Canadian adult-use cannabis | 57,235 | 94 | % | 71,195 | 102 | % | |||||||
| Revenue from wholesale cannabis | 5,507 | 9 | % | 5,295 | 7 | % | |||||||
| Revenue from international cannabis | 12,191 | 20 | % | 14,252 | 20 | % | |||||||
| Less excise taxes | (19,945 | ) | (33 | )% | (26,551 | ) | (38 | )% | |||||
| Total | $ | 61,249 | 100 | % | $ | 70,333 | 100 | % | |||||
| Net Cannabis Revenue by Market Channel in Constant Currency | |||||||||||||
| For the three months ended | For the three months ended | ||||||||||||
| August 31, 2024 | August 31, 2023 | ||||||||||||
| (In thousands of U.S. dollars) | as reported in constant currency | % of Total Revenue | as reported in constant currency | % of Total Revenue | |||||||||
| Revenue from Canadian medical cannabis | $ | 6,432 | 10 | % | $ | 6,142 | 9 | % | |||||
| Revenue from Canadian adult-use cannabis | 58,806 | 94 | % | 71,195 | 102 | % | |||||||
| Revenue from wholesale cannabis | 5,658 | 9 | % | 5,295 | 7 | % | |||||||
| Revenue from international cannabis | 12,388 | 20 | % | 14,252 | 20 | % | |||||||
| Less excise taxes | (20,492 | ) | (33 | )% | (26,551 | ) | (38 | )% | |||||
| Total | $ | 62,792 | 100 | % | $ | 70,333 | 100 | % | |||||
| Other Financial Information: Key Operating Metrics | |||||||
| For the three months ended | |||||||
| August 31, | August 31, | ||||||
| (in thousands of U.S. dollars) | 2024 | 2023 | |||||
| Net beverage alcohol revenue | $ | 55,972 | $ | 24,162 | |||
| Net cannabis revenue | 61,249 | 70,333 | |||||
| Distribution revenue | 68,071 | 69,157 | |||||
| Wellness revenue | 14,752 | 13,297 | |||||
| Beverage alcohol costs | 33,050 | 11,266 | |||||
| Cannabis costs | 37,054 | 50,517 | |||||
| Distribution costs | 60,138 | 61,468 | |||||
| Wellness costs | 10,096 | 9,502 | |||||
| Adjusted gross profit (excluding PPA step-up) | 59,881 | 49,302 | |||||
| Beverage alcohol adjusted gross margin (excluding PPA step-up) | 41 | % | 56 | % | |||
| Cannabis adjusted gross margin (excluding PPA step-up) | 40 | % | 35 | % | |||
| Distribution gross margin | 12 | % | 11 | % | |||
| Wellness gross margin | 32 | % | 29 | % | |||
| Adjusted EBITDA | $ | 9,334 | $ | 10,734 | |||
| Cash and marketable securities as at the period ended: | 280,055 | 466,465 | |||||
| Working capital as at the period ended: | $ | 432,334 | $ | 291,981 | |||
| Other Financial Information: Gross Margin and Adjusted Gross Margin | |||||||||||||||||||
| For the three months ended August 31, 2024 | |||||||||||||||||||
| (In thousands of U.S. dollars) | Beverage | Cannabis | Distribution | Wellness | Total | ||||||||||||||
| Net revenue | $ | 55,972 | $ | 61,249 | $ | 68,071 | $ | 14,752 | $ | 200,044 | |||||||||
| Cost of goods sold | 33,050 | 37,054 | 60,138 | 10,096 | 140,338 | ||||||||||||||
| Gross profit | 22,922 | 24,195 | 7,933 | 4,656 | 59,706 | ||||||||||||||
| Gross margin | 41 | % | 40 | % | 12 | % | 32 | % | 30 | % | |||||||||
| Adjustments: | |||||||||||||||||||
| Purchase price accounting step-up | 175 | — | — | — | 175 | ||||||||||||||
| Adjusted gross profit | 23,097 | 24,195 | 7,933 | 4,656 | 59,881 | ||||||||||||||
| Adjusted gross margin | 41 | % | 40 | % | 12 | % | 32 | % | 30 | % | |||||||||
| For the three months ended August 31, 2023 | |||||||||||||||||||
| (In thousands of U.S. dollars) | Beverage | Cannabis | Distribution | Wellness | Total | ||||||||||||||
| Net revenue | $ | 24,162 | $ | 70,333 | $ | 69,157 | $ | 13,297 | $ | 176,949 | |||||||||
| Cost of goods sold | 11,266 | 50,517 | 61,468 | 9,502 | 132,753 | ||||||||||||||
| Gross profit | 12,896 | 19,816 | 7,689 | 3,795 | 44,196 | ||||||||||||||
| Gross margin | 53 | % | 28 | % | 11 | % | 29 | % | 25 | % | |||||||||
| Adjustments: | |||||||||||||||||||
| Purchase price accounting step-up | 590 | 4,516 | — | — | 5,106 | ||||||||||||||
| Adjusted gross profit | 13,486 | 24,332 | 7,689 | 3,795 | 49,302 | ||||||||||||||
| Adjusted gross margin | 56 | % | 35 | % | 11 | % | 29 | % | 28 | % | |||||||||
| Other Financial Information: Adjusted Earnings Before Interest, Taxes and Amortization | ||||||||||||||
| For the three months ended | ||||||||||||||
| August 31, | August 31, | Change | % Change | |||||||||||
| (In thousands of U.S. dollars) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||
| Net loss | $ | (34,652 | ) | $ | (55,863 | ) | $ | 21,211 | (38 | )% | ||||
| Income tax expense, net | 886 | 7,264 | (6,378 | ) | (88 | )% | ||||||||
| Interest expense, net | 9,842 | 9,835 | 7 | 0 | % | |||||||||
| Non-operating income (expense), net | (12,646 | ) | 4,402 | (17,048 | ) | (387 | )% | |||||||
| Amortization | 31,814 | 30,789 | 1,025 | 3 | % | |||||||||
| Stock-based compensation | 6,917 | 8,257 | (1,340 | ) | (16 | )% | ||||||||
| Change in fair value of contingent consideration | — | (11,107 | ) | 11,107 | (100 | )% | ||||||||
| Purchase price accounting step-up | 175 | 5,106 | (4,931 | ) | (97 | )% | ||||||||
| Facility start-up and closure costs | — | 600 | (600 | ) | (100 | )% | ||||||||
| Litigation costs, net of recoveries | 1,595 | 2,034 | (439 | ) | (22 | )% | ||||||||
| Restructuring costs | 4,247 | 915 | 3,332 | 364 | % | |||||||||
| Transaction costs (income) | 1,156 | 8,502 | (7,346 | ) | (86 | )% | ||||||||
| Adjusted EBITDA | $ | 9,334 | $ | 10,734 | $ | (1,400 | ) | (13 | )% | |||||
| Other Financial Information: Adjusted Net Loss and Adjusted Net Loss Per Share | For the three months ended | |||||||||||||
| August 31, | August 31, | Change | % Change | |||||||||||
| 2024 | 2023 | Change | ||||||||||||
| Net loss attributable to stockholders of Tilray Brands, Inc. | $ | (39,165 | ) | $ | (71,525 | ) | $ | 32,360 | (45 | )% | ||||
| Non-operating income (expense), net | (12,646 | ) | 4,402 | (17,048 | ) | (387 | )% | |||||||
| Amortization | 31,814 | 30,789 | 1,025 | 3 | % | |||||||||
| Stock-based compensation | 6,917 | 8,257 | (1,340 | ) | (16 | )% | ||||||||
| Change in fair value of contingent consideration | — | (11,107 | ) | 11,107 | (100 | )% | ||||||||
| Facility start-up and closure costs | — | 600 | (600 | ) | (100 | )% | ||||||||
| Litigation costs, net of recoveries | 1,595 | 2,034 | (439 | ) | (22 | )% | ||||||||
| Restructuring costs | 4,247 | 915 | 3,332 | 364 | % | |||||||||
| Transaction costs (income) | 1,156 | 8,502 | (7,346 | ) | (86 | )% | ||||||||
| Adjusted net loss | $ | (6,082 | ) | $ | (27,133 | ) | $ | 21,051 | (78 | )% | ||||
| Adjusted net loss per share - basic and diluted | $ | (0.01 | ) | $ | (0.04 | ) | $ | 0.03 | (75 | )% | ||||
| Other Financial Information: Free Cash Flow | ||||||||||||||
| For the three months ended | ||||||||||||||
| August 31, | August 31, | Change | % Change | |||||||||||
| (In thousands of U.S. dollars) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||
| Net cash used in operating activities | $ | (35,307 | ) | $ | (15,842 | ) | $ | (19,465 | ) | 123 | % | |||
| Less: investments in capital and intangible assets, net | (6,708 | ) | (3,810 | ) | (2,898 | ) | 76 | % | ||||||
| Free cash flow | $ | (42,015 | ) | $ | (19,652 | ) | $ | (22,363 | ) | 114 | % | |||
| Add: growth CAPEX | 2,540 | 1,687 | 853 | 51 | % | |||||||||
| Add: cash income taxes related to Aphria Diamond | — | 5,714 | (5,714 | ) | (100 | )% | ||||||||
| Add: integration costs related to HEXO | — | 5,915 | (5,915 | ) | (100 | )% | ||||||||
| Adjusted free cash flow | $ | (39,475 | ) | $ | (6,336 | ) | $ | (33,139 | ) | 523 | % | |||
FAQ
What was Tilray's (TLRY) Q1 2025 net revenue?
How much did Tilray's (TLRY) beverage alcohol segment grow in Q1 2025?
What was Tilray's (TLRY) gross margin in Q1 2025?
How did Tilray's (TLRY) net loss change in Q1 2025 compared to the previous year?
What was Tilray's (TLRY) cannabis net revenue in Q1 2025?
